Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine added to morphine versus morphine alone after coronary artery bypass graft surgery
IRCT20130311012782N39Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexmedetomidine and morphine, sponsored by Isfahan University of Medical Sciences. Started Apr 2020; status: completed.
02
Drugs
dexmedetomidinemorphine
Beyond the preview
Go deeper on IRCT20130311012782N39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130311012782N39.